BioSpace News Archive

Capricor Therapeutics today announced positive one-year results from its HOPE-2 open label extension study in non-ambulant patients with later-stage Duchenne muscular dystrophy (DMD).

Medtronic plc (NYSE: MDT) today announced that its Board of Directors appointed Lidia Fonseca, Executive Vice President, Chief Digital and Technology Officer at Pfizer, to the Board as an independent director, effective June 27, 2022.

Hamsters Receiving Ainos’ VELDONA Formulation Demonstrate Protection from COVID-19 Based on Prespecified Indicators of Clinical Outcomes.

Nanoscope Therapeutics , Inc., a clinical-stage biotechnology company developing gene therapies to treat retinal degenerative diseases, today announced that CEO and Co-Founder Sulagna Bhattacharya has been named a winner of Ernst & Young’s Entrepreneur Of The Year® 2022 Central Plains Award.

Visby Medical™ , a leading medical diagnostic company, announced in an internal communication to employees Friday that the company will provide travel benefits for any employee, or their dependents, to travel to another state to obtain safe and legal pregnancy-related care.

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will host a virtual R&D Day on July 12, 2022 at 12:00 pm ET.

Paraza Pharma is pleased to announce the appointment of Dr. Chudi Ndubaku as Chief Scientific Officer.

Wilmington, Delaware, United States: Female-centric health technology and wellness products have emerged as vastly lucrative market.

Fact.MR – A Market Research and Competitive Intelligence Provider: High adoption of surgical laser systems in cosmetic surgeries, refractive eye surgeries, dental procedures, and general surgeries such as tumour removal, cataract removal, plastic surgery, and many others has led this market to record sales worth US$ 2.94 Bn in the year 2021.

Argenta today announced that Paul Fry will join the company as its new Chief Financial Officer, starting immediately. To ensure a smooth transition, Paul will work closely with former CFO Chris O’Donnell until late August.